France wins larger share of patent royalties after AIDS test dispute
نویسندگان
چکیده
منابع مشابه
Injunctions, Hold-Up, and Patent Royalties
This paper studies royalty negotiations between a patent holder and a downstream firm selling a product which is more valuable if it includes a feature covered by the patent. Royalties are negotiated in the shadow of patent litigation, which will determine whether or not the patent is valid and infringed. If the two firms negotiate after the downstream firm has already designed its product to i...
متن کاملDo Patent Holdup and Royalty Stacking Lead to Systematically Excessive Royalties?
Some recent literature has concluded that patent remedies result in systematically excessive royalties because of holdup and stacking problems. This article shows that this literature is mistaken. The royalty rates predicted by the holdup models are often (plausibly most of the time) below the true optimal rate. Further, those predicted royalty rates are overstated because of incorrect assumpti...
متن کاملInnovative marketing strategies after patent expiry: The case of GSK’s antibiotic Clamoxyl in France
is Assistant Professor of Marketing at INSEAD, where he teaches brand management to MBAs and executives. His area of expertise is in brand management and in consumer behaviour for low-involvement products, with applications in the areas of sales promotions and point-of-purchase marketing. He has published articles and books on these topics in leading academic journals, including the Journal of ...
متن کاملCoil occlusion for patent ductus arteriosus larger than 3 mm.
BACKGROUND Coil occlusion of patent ductus arteriosus (PDA) is now widely accepted as the first-line treatment, but there are few reports of age-dependent differences in the complications associated with this technique. METHODS AND RESULTS Sixteen patients (11 adults, 5 children) with a PDA larger than 3 mm, who underwent coil occlusion at Sapporo Medical University Hospital between September...
متن کاملSARS genome patent: to manage and to share.
The most likely explanation for the conflicting results of the two analyses is the different statistical program used by John Geddes and colleagues. Metaregression is a fairly new technique that is still evolving; it is suitable to explore reasons for heterogeneity, but the results must be interpreted with caution. Graphical plots should always be drawn, but in plots of either risk differences ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1994
ISSN: 0028-0836,1476-4687
DOI: 10.1038/370085a0